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Abstract
The release and uptake of nano-sized extracellular vesicles (EV) is a highly conserved means of intercellular communication. 
The molecular composition of EV, and thereby their signaling function to target cells, is regulated by cellular activation and 
differentiation stimuli. EV are regarded as snapshots of cells and are, therefore, in the limelight as biomarkers for disease. 
Although research on EV-associated RNA has predominantly focused on microRNAs, the transcriptome of EV consists of 
multiple classes of small non-coding RNAs with potential gene-regulatory functions. It is not known whether environmental 
cues imposed on cells induce specific changes in a broad range of EV-associated RNA classes. Here, we investigated whether 
immune-activating or -suppressing stimuli imposed on primary dendritic cells affected the release of various small non-
coding RNAs via EV. The small RNA transcriptomes of highly pure EV populations free from ribonucleoprotein particles 
were analyzed by RNA sequencing and RT-qPCR. Immune stimulus-specific changes were found in the miRNA, snoRNA, 
and Y-RNA content of EV from dendritic cells, whereas tRNA and snRNA levels were much less affected. Only part of the 
changes in EV-RNA content reflected changes in cellular RNA, which urges caution in interpreting EV as snapshots of cells. 
By comprehensive analysis of RNA obtained from highly purified EV, we demonstrate that multiple RNA classes contribute 
to genetic messages conveyed via EV. The identification of multiple RNA classes that display cell stimulation-dependent 
association with EV is the prelude to unraveling the function and biomarker potential of these EV-RNAs.
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Abbreviations
BSA  Bovine serum albumin
DC  Dendritic cell
EV  Extracellular vesicles
LPS  Lipopolysaccharide
miRNA/miR  MicroRNA
miscRNA  Miscellaneous RNA
ncRNA  Non-coding RNA
RNP  Ribonucleoprotein (complex)
rRNA  Ribosomal RNA
snRNA  Small nuclear RNA
snoRNA  Small nucleolar RNA
TLR  Toll-like receptor
tRNA  Transfer RNA
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Introduction
Extracellular vesicles (EV) released by cells are consid-
ered as important mediators of intercellular communica-
tion [1, 2]. These 50–200 nm-sized vesicles are released 
by a broad range of cells, and have been detected in a 
wide range of body fluids, such as milk, plasma, urine, and 
semen [1, 3]. The collective term ‘EV’ refers to a hetero-
geneous population of secreted vesicles that are formed via 
different pathways. Exosomes are formed as intraluminal 
vesicles (ILVs) inside multi-vesicular endosomes (MVE) 
and are released upon fusion of the MVE with the plasma 
membrane, whereas microvesicles directly bud off from 
the plasma membrane [1]. These vesicle populations over-
lap in size and molecular composition, which currently 
hampers their discrimination based on biophysical or bio-
chemical parameters [4–6].
EV are multi-component entities that transfer proteins, 
lipids, and RNA between cells. The RNA associated with 
EV mainly consists of small non-coding RNA species 
(ncRNA), which are thought to be of major importance 
in altering molecular processes in the recipient cell [3, 4, 
7, 8]. In addition, the RNA composition of EV can give 
information about the (patho)physiological status of the 
EV-producing cell. Since EV can be easily obtained from 
body fluids, such EV-associated RNAs may be used as 
non-invasive biomarkers for the early detection of dis-
ease [9, 10]. The molecular composition of EV is often 
assumed to be a ‘snapshot’ of the producing cell, from 
which the tissue type or mutational status of the parental 
cell can be deduced [9, 11, 12].
Although the EV-RNA field receives major attention, 
with quickly rising numbers of publications on this topic, 
the technical difficulties to obtain pure EV remain under-
exposed. It is important to note that a substantial amount 
of extracellular RNA is not contained in EV, but is associ-
ated with ribonucleoprotein particles (RNPs), including 
argonaute 2 (AGO2), or lipoprotein complexes [13–15]. 
These contaminating structures have been shown to co-
isolate together with EV via commonly used isolation pro-
cedures, and may, therefore, greatly affect the outcomes 
of experiments [4, 5, 16]. The currently most reliable 
method to obtain pure EV is by high-speed ultracentrifu-
gation followed by density centrifugation in which EV are 
separated from contaminating structures based on differ-
ences in buoyant density [16]. Subsequently, analyzing the 
presence of common EV markers (such as CD9, CD63, 
and CD81) and absence of contaminant proteins should 
be performed to assess the purity of EV preparations used 
in the study [17, 18].
MiRNAs are the most intensely studied type of small 
RNA in EV, likely due to the interest in gene-regulatory 
functions of these RNAs [19–21]. It has been shown that 
changes in the activation status of the EV-producing cell 
lead to changes in the EV-miRNA composition [22–24]. 
Moreover, miRNAs in EV were shown to be functionally 
transferred between cells, leading to repression of genes 
in target cells [25, 26]. It is, therefore, thought that differ-
ences in the miRNA content of EV underlie distinct func-
tional effects of EV released by differentially stimulated 
cells [22–24]. In addition, changes in EV-miRNA levels in 
plasma or serum have been associated with diseases such 
as cancer, rheumatoid arthritis, and Alzheimer’s disease 
[27–29].
Despite the interest in miRNAs, a larger part of EV-
associated RNA consists of other ncRNA classes. We and 
others previously showed that EV released by cultured cells 
and EV present in a variety of body fluids contain many 
other small non-coding RNA species (20–300 nt), such as 
tRNA, snoRNA, snRNA, Y-RNA, Vault RNA, and SRP-
RNA (also named 7SL) [23, 30–35]. Some of these non-
coding RNAs are relatively enriched in EV, suggesting that 
these RNAs are specifically shuttled into EV for release into 
the extracellular milieu. Inside cells, the above-mentioned 
non-coding RNAs are known to play a role in basic cellular 
processes such as translation, RNA splicing, and RNA qual-
ity surveillance. Recent studies showed that full-length and 
fragmented forms of these non-coding RNAs can addition-
ally be involved in other processes including immunological 
signaling, gene regulation, and guiding of other RNAs and 
nucleases [36–41]. However, it is not known whether activa-
tion stimuli imposed on the EV-producing cell affect the lev-
els of these ncRNA classes in EV, similar to EV-associated 
miRNAs. Evaluation of cell stimulation-dependent changes 
in EV-associated ncRNA classes is a first step in uncovering 
their function in EV-mediated signaling processes and their 
potential as biomarkers indicative of the activation status 
of cells.
Here, we studied how changes in the activation/differen-
tiation status of the parental cell affect the small non-coding 
RNA content of EV by employing a primary immune cell 
model, two different types of cell stimulation, and methods 
yielding highly pure EV populations. For our analysis, we 
used primary dendritic cells (DC), which are master regu-
lators of immune responses and have been shown to com-
municate with various other immune cells via EV [2, 8, 42]. 
In addition, the use of DC-derived EV has been proposed 
as a strategy for cancer immune(chemo)therapy [43–46]. 
Depending on external stimuli, DC can be differentiated 
into functionally different phenotypes that either activate or 
down-regulate immune responses [47]. These DC, therefore, 
present a suitable model to investigate how different external 
stimuli affect incorporation of a broad range of RNA classes 
into EV. We compared cellular and EV-associated RNA lev-
els in control, immune-stimulating, or immune-suppressing 
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DC conditions using RNA deep sequencing and RT-qPCR. 
Our data indicate that differentiation signals imposed on 
dendritic cells affect the EV-associated levels of particular 
RNA classes, such as miRNA, snoRNA, and Y-RNA, while 
other non-coding RNA types remain largely unchanged. 
Moreover, only a minor part of the stimulation-induced 
changes in EV-RNA content reflects changes in cellular 
RNA levels. This study exemplifies how comprehensive 
analysis of RNA obtained from highly purified EV yields 
candidate small ncRNAs beyond miRNAs for further explo-
ration as biomarkers or functional entities within EV.
Materials and methods
Cell culture
Complete culture medium was prepared by supplementing 
Iscove’s Modified Dulbecco’s Medium (IMDM, Lonza, 
Verviers, Belgium) with 2 mM Ultraglutamine (Lonza, 
Verviers, Belgium), 10% fetal calf serum (FCS, GE Health-
care Bio-Sciences, Pasching, Austria), 100 IU/ml penicil-
lin and 100 μg/ml streptomycin (Gibco, Paisley, United 
Kingdom), and 50 µM β-mercaptoethanol. The GM-CSF 
producing NIH 3T3 cell line (R1) was grown in complete 
medium. Primary bone marrow cells were grown in com-
plete medium supplemented with 30% conditioned medium 
from R1 cells. To prepare EV-depleted medium, a mixture of 
150 ml conditioned R1 culture supernatant and 42.5 ml FCS 
(end concentration 30% FCS) was depleted of EV by over-
night centrifugation at 100,000g in an SW28 rotor (k-factor 
334.2) (Beckman Coulter, Brea, CA). The EV-depleted 
supernatant was carefully pipetted from the tubes, leaving 
5 ml in the tubes to prevent disturbance of the pellet. This 
supernatant was filtered through a 0.22 μm bottle top filter 
(Millipore, Billerica, MA) after which additional IMDM, 
ultraglutamine, antibiotics, and β-mercaptoethanol were 
added to prepare complete medium as indicated above. The 
efficiency of EV depletion from culture medium, as regu-
larly assessed by high-resolution flow cytometric analy-
sis, is on average ~ 90%. Primary bone marrow cells were 
flushed from the femur and tibia of 8–12-week-old C57bl/6 
mice and differentiated to dendritic cells according to Lutz 
et al. [48]. To generate tolerogenic DC, cells were treated 
from day 2 onward with 10 nM 1α,25-dihydroxyvitaminD3 
(Sigma, St Louis, MO). To generate immunogenic DC, 1 µg/
ml lipopolysaccharide (LPS, cat. L-2630, Sigma, St. Louis, 
MO) was added on day 12. On day 13, non-adherent and 
semi-adherent cells were recovered and cultured at 3 × 106 
cells/dish for 20 h in EV-depleted culture medium. Cell via-
bility, as determined by Trypan blue exclusion, did not differ 
between treatments and was above 90% for all cultures. All 
cells were maintained at 37 °C and 5%  CO2 in a humidified 
incubator. Experiments were approved by the institutional 
ethical animal committee at Utrecht University (Utrecht, The 
Netherlands).
Flow cytometry
Day 12 bone marrow DC (BMDC) were collected and 
labeled for 30 min in PBS + 1% BSA (Bovine Serum Albu-
min, cat. K45-001, GE Healthcare Bio-Sciences, Pasch-
ing, Austria) containing anti-CD11c-APC (eBioscience, 
clone N418, 1:400), anti-MHCII-FITC (eBioscience, clone 
M5/114.15.2, 1:1500), and anti-CD40-PE (BD Biosciences, 
clone 3/23, 1:200), or anti-CD86-PE (eBioscience, clone 
GL1, 1:200) or anti-CD274-PE (PD-L1, eBioscience, clone 
M1H5, 1:400). As control, corresponding isotype control 
antibodies (eBioscience, San Diego, CA) were used. Sur-
face labeling was analyzed using a FACS Calibur Flow 
Cytometer (BD Biosciences, San Jose, CA). Data analysis 
was performed using FCS Express V3 (DeNovo Software, 
Glendale, CA).
Fluorescent labeling and purification of EV
Conditioned cell supernatants were pooled to volumes of 
100–140 ml per condition and were subjected to differential 
centrifugation as described previously [49]. In brief: super-
natant was sequentially centrifuged 2 × 200g for 10 min, 
2 × 500g for 10 min, and 1 × 10,000g for 30 min. Next, EV 
were pelleted by ultracentrifugation at 100,000g for 65 min 
using an SW28 rotor (k-factor 334.2) (Beckman Coulter, 
Brea, CA). For EV quantification by high-resolution flow 
cytometry, pellets were resuspended in 20 µl PBS + 0.2% 
BSA (cleared from aggregates by overnight ultracentrifuga-
tion at 100,000g) and labeled with 1.5 µl PKH67 (Sigma, 
St. Louis, MO) in 100 µl Diluent C per pellet. For EV-RNA 
isolation, 100,000  g pellets were resuspended in 50  µl 
PBS + 0.2% BSA. PKH67-labeled samples or samples for 
RNA isolation were mixed with 1.5 ml 2.5 M sucrose, and 
overlaid with a linear sucrose gradient (2.0–0.4 M sucrose in 
PBS). Gradients were centrifuged 15–18 h at 192,000g in a 
SW40 rotor (k-factor 144.5) (Beckman Coulter, Brea, CA). 
PKH67-labeled EV were used for high-resolution flow cyto-
metric analysis (see below). Alternatively, the fractions with 
densities of 1.12–1.18 g/ml (as measured by refractometry) 
were pooled, diluted six times in PBS + 0.2% EV-depleted 
BSA, and centrifuged again at 192,000g for 65 min in a 
SW40 rotor (k-factor 144.5) prior to EV-RNA isolation.
RNA isolation
Small RNA was isolated from EV pellets and from 1 × 106 
cells using the miRNeasy Micro kit according to the small 
RNA enrichment protocol provided by the manufacturer 
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(Qiagen, Hilden, Germany). RNA yield and size profile were 
assessed using the Agilent 2100 Bioanalyzer with Pico 6000 
RNA chips (Agilent Technologies, Waldbronn, Germany).
Preparation of small RNA sequencing libraries
50 ng cellular small RNA and 2 ng EV-derived small RNA 
was treated with DNase [Turbo DNA-free kit (Life Tech-
nologies, Carlsbad, CA)] according to the manufacturer’s 
instructions. The DNase-treated RNA was pelleted using 
Pellet Paint (Merck, Darmstadt, Germany) according to the 
manufacturer’s instructions, reconstituted in milliQ (MQ) 
and subsequently subjected to ribosomal RNA depletion 
using RiboZero Gold kit (Human/Mouse/Rat) (Illumina, 
San Diego, CA) according to the manufacturer’s instruc-
tions. This is required to deplete residual rRNA from cel-
lular RNA samples and, for comparability, we subjected EV-
RNA samples to the same procedure. Hereafter, RNA was 
pelleted with Pellet Paint and reconstituted into 6 µl MQ. 
cDNA libraries were prepared using the NebNext smallRNA 
library prep kit for Illumina (New England Biolabs, Ipswich, 
MA), according to the manufacturer’s instructions but with 
the following adaptations: 3′ adapter-ligation was carried 
out overnight at 16 °C; PCR amplification was done using 
Kapa HiFi Readymix 2× PCR mastermix (Kapa Biosystems, 
Wilmington, MA) using barcoded primers and the follow-
ing PCR programme: 2 min at 95 °C, 15 cycles of 20 s at 
98 °C, 30 s at 62 °C, 15 s at 70 °C, and a final elongation 
step of 5 min at 70 °C. cDNA was purified using magnetic 
AMPure XP beads (Beckman Coulter, Brea, CA) and quan-
tified using Agilent 2100 Bioanalyzer and DNA HiSensi-
tivity chips (Agilent Technologies, Waldbronn, Germany). 
Adapter dimers (126 nt in size) were removed by running 
the cDNA on 6% TBE gels (Life Technologies, Carlsbad, 
CA) for 60 min at 145 V, after which cDNA products of 
15–300 nt (+ 126 nt adapters) were cut from the gel and 
purified. Subsequently, all libraries were pooled at equimo-
lar ratios and run on a 4–12% TBE gel (Life Technologies, 
Carlsbad, CA). Size fractions of 15–25 nt (includes miR-
NAs), 25–60 nt, 60–80 nt (includes tRNAs), and 80–275 nt 
(each + 126 nt adapters) were cut from the gel, and purified 
and pooled in a volumetric ratio of 2:2:3:3. Sequencing was 
done using 150 bp paired-end reads on an Illumina HiSeq 
4000 machine (Illumina, San Diego, CA) at ServiceXS (Lei-
den, The Netherlands).
RNAseq data analysis
All data was processed as paired-end reads. Data qual-
ity was checked with FastQC and reads were processed 
with cutadapt (version 1.8) to remove low-quality reads, 
clip the reads to 100 bp, and remove adapter sequences. 
Sequences with a minimal length of 17 bp after adapter 
trimming were retained to ensure high quality reads (cut-
adapt -q 30 -u -51 -U -51 -n1 --minimum-length 17 -a 
AGA TCG GAA GAG CAC ACG TCT GAA C -A GAT CGT 
CGG ACT GTA GAA CTC TGA A). Reads were mapped 
to the mouse genome mm10 using gsnap (v2014-12-23; 
gsnap --novelsplicing 1 --npaths 3 --format sam). Count 
tables were prepared using Htseq (v0.6.1p1; htseq-count 
--minaqual 0 --format bam --order pos --stranded yes). For 
miRNA count tables, miRbase v20 annotation was used. 
Gene annotation for snoRNA, snRNA, and miscRNA was 
retrieved from Biomart (Ensembl 84). tRNA and rRNA 
chromosomal positions were retrieved from the UCSC 
mm10 repeat mask track. Reproducibility of triplicate 
experiments (performed on different days) was assessed 
by evaluating Pearson correlation values (after logarithmic 
transformation of the small RNA counts).
Differential abundance was determined separately for 
each ncRNA class, and separately for EV and cells, using 
the edgeR package in R [50]. Data were normalized using 
the TMM method (weighted trimmed mean of M values). 
Estimating the common, trended (overexpression values), 
and tagwise dispersion, a generalized linear model, con-
taining the effect of cell stimulation and the effect of the 
day-to-day variation between triplicate experiments, was 
fit. The log-likelihood ratio test was used to evaluate dif-
ferential expression between treatments relative to control. 
p values were adjusted for multiple testing using Benja-
mini and Hochberg’s false discovery rate (FDR). Average 
fold-change over three independent experiments and stand-
ard deviation were plotted. Analysis of RNA fragments 
was done using the UCSC genome browser and Integrated 
Genome Viewer [51].
Quantitative real‑time PCR
cDNA was generated from cellular or EV-derived small 
RNA using the miScript RT2 kit (Qiagen, Hilden, Ger-
many). An equivalent of 20 pg RNA was used per qPCR 
reaction and mixed with 100 nM primers (Isogen Life Sci-
ences, De Meern, The Netherlands) and 4 µl SYBR Green 
Sensimix (Bioline Reagents Ltd., United Kingdom) in an 
8 µl reaction. No-RT-controls confirmed the absence of 
genomic DNA and non-specific amplification.
Cycling conditions were 95 °C for 10 min followed by 
50 cycles of 95 °C for 10 s, 57 °C for 30 s, and 72 °C for 
20 s. All PCR reactions were performed on the Bio-Rad 
iQ5 Multicolor Real-Time PCR Detection System (Bio-
Rad, Hercules, CA). Quantification cycle (Cq) values were 
determined using Bio-Rad CFX software using automatic 
baseline settings. Thresholds were set in the linear phase 
of the amplification curve.
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High‑resolution flow cytometric analysis of EV
High-resolution flow cytometric analysis of PKH67-
labeled EV was performed using a BD Influx flow cytom-
eter (BD Biosciences, San Jose, CA) with an optimized 
configuration, as previously described [49, 52]. In brief, 
we applied threshold triggering on fluorescence derived 
from PKH67-labeled EV passing the first laser. Forward 
scatter (FSC) was detected with a collection angle of 
15°–25° (reduced wide-angle FSC). Fluorescent 100- 
and 200-nm polystyrene beads (FluoSpheres, Invitrogen, 
Carlsbad, CA) were used to calibrate the fluorescence and 
rw-FSC settings. Sucrose gradient fractions containing 
PKH67-labeled EV were diluted 25× in PBS and vor-
texed just before measurement. This dilution factor was 
sufficient to avoid ‘coincidence’ (multiple EV arriving 
at the measuring spot at the same time), thereby allowing 
accurate quantitative comparison of EV numbers in dif-
ferent conditions. Moreover, samples were measured at 
maximally 10,000 events per second, which is far below 
the limit in the electronic pulse processing speed of the 
BD Influx [53].
Western blotting
Cell pellets were lyzed in PBS + 1% Nonidet-P40 with 
protein inhibitor cocktail (Roche, Basel, Switzerland) for 
15 min on ice. Nuclei were spun down at 16,000 g for 
15 min at 4 °C, supernatant was used for Western blotting. 
Cell lysates and EV were denatured in SDS-sample buffer 
at 100 °C for 3 min, and separated using 12% SDS-PAGE 
gels, after which proteins were transferred onto Immo-
bilon-P 0.45 μm PVDF membranes (Millipore, Cork, Ire-
land). After blocking for 1–2 h in blocking buffer (0.5% 
Cold Fish Skin Gelatin (Sigma-Aldrich, St. Louis, CA) in 
PBS + 0.05% Tween-20), blots were incubated overnight 
at 4 °C with primary antibodies [anti-mouse-CD9 (eBio-
science, clone KMC8, 1: 1000), anti-mouse-CD63 (MBL, 
clone D263-3, 1:1000), anti-mouse–galectin-3 (eBiosci-
ence, clone M3/38, 1:500), anti-MHCII-p55 (GenScript, 
Piscataway, NJ, custom Ab raised against MHCII bèta 
chain peptide sequence RSQKGPRGPPPAGLLQC, 
1:5000), or anti-mouse-beta-actin (ThermoScientific, 
polyclonal PA1-16889, 1:5000)] in blocking buffer, and 
washed and incubated for 1–2 h with HRP-coupled sec-
ondary antibodies (Dako, cat P0450 and P0448, 1:5000). 
ECL solution (ThermoScientific, SuperSignal West Dura 
Extended Duration Substrate, cat. 34075) was used for 
detection on a Chemidoc imager (Bio-Rad, Hercules, 
CA). Images were analyzed by the Image Lab software 
(Bio-Rad, Hercules, CA).
Nanoparticle tracking analysis (NTA)
EV purified by density gradient ultracentrifugation as 
described above were resuspended in 50 µl PBS + 0.4% 
EV-depleted BSA. Samples were diluted 20 times in PBS 
(confirmed to be particle-free when analyzed with the same 
settings as used for the EV samples) before measurement 
on a Nanosight NS500 instrument (Malvern, Worchester-
shire, UK). Data acquisition and processing were performed 
using NTA software 3.1. Each sample was recorded for 5 
times 30 s, 25 frames per second, camera level 14, detection 
threshold 5.
Electron microscopy
EV and RNP were separated by density gradient centrifuga-
tion as described above, and resuspended in 15 µl PBS. 3 µl 
aliquots of either EV or RNP were added on top of carbon-
coated 300 mesh, copper grids, and incubated for 2 min at 
room temperature. The grids were then washed two times 
in 50 µl PBS and stained with 2% uranyl acetate. Imaging 
was performed on a T20 electron microscope (FEI) operated 
at 200 keV. Images were recorded on a CCD Eagle camera 
(FEI).
Northern blotting
Cellular or EV-derived small RNA (between 100 ng and 
1 ng per lane, as indicated) was denatured in gel loading 
buffer II (Invitrogen) for 2 min at 70 °C and snap-cooled on 
ice before loading on a denaturing 15% PAGE gel (National 
Diagnostics, Nottingham, UK) as described previously [54]. 
RNA was transferred onto a Hybond-N Nylon membrane 
(Amersham Pharmacia Biotech, GE Healthcare Bio-Sci-
ences, Pasching, Austria) and chemically crosslinked with 
1-ethyl-3-(3-dimethylaminopropyl) carbodimide (Sigma) at 
55 °C for 2 h [55]. 32P-labeled DNA oligo probes perfectly 
complementary to each RNA species were hybridized over-
night at 42 °C in PerfectHyb (Sigma) solution. Blots were 
analyzed by phosphorimaging using a Typhoon Scanner (GE 
Healthcare).
List of DNA oligo probes
RT‑qPCR probes
The following forward primers were used in RT-qPCR (5′ 
to 3′) in combination with the miScript universal reverse 
primer.
miR-146a-5p  TGA GAA CTG AAT TCC ATG GGT 
miR-155-5p  GGG TTA ATG CTA ATT GTG ATA G
miR-9-5p  GGG TCT TTG GTT ATC TAG C
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miR-10a-5p  TAC CCT GTA GAT CCG AAT TTG TG
miR-27b-3p  TTC ACA GTG GCT AAG TTC TGC 
miR-378-5p  ACT GGA CTT GGA GTC AGA AG
mY1  GTT ATC TCA ATT GAT TGT TCA CAG 
TC
mY3  GGC TGG TCC GAG TGC AGT GG
RNU1  CCA TGA TCA CGA AGG TGG TTT 
RNU6  CTC GCT TCG GCA GCACA 
snord65  TAG TGG TGA GCC TAT GGT TTT 
snord68  AGT ACT TTT GAA CCC TTT TCCA 
Northern oligo’s
Y1_5p  TTG AGA TAA CTC ACT ACC TTC 
GGA CCA GCC 
Y1_3p  GTC AAG TGC AGT AGT GAG 
AAG 
5′-tRNA-Glu_CTC  CCG AAT CCT AAC CAC TAG ACC 
ACC AG
5′-tRNA-Gly_GTT  GCA TTG GTG GTT CAG TGG TAG 
AAT TCT CGC C
Statistical analyses
Differences between the numbers of EV released by LPS- 
and VitD3-stimulated DC versus control DC were analyzed 
by one-way ANOVA with Dunnett’s two-sided post hoc test. 
Similar statistical testing was performed on differences in 
RNA yield. Differences in RNA biotypes in EV and cells 
were analyzed by two-tailed t test. Differences in fold-
changes of individual RNAs as measured in RT-qPCR were 
analyzed by one-way ANOVA. Significance was defined 
as p < 0.05. Statistical tests on data not derived from RNA 
sequencing were done in SPSS (v24, IBM).
Availability of data and materials
Raw data and count tables are deposited in the GEO data-
base under accession number GSE105151. Written details 
on experimental procedures have been submitted to the EV-
TRACK knowledgebase (EV-TRACK ID: EV170030) [5].
Results
Functionally distinct subsets of mouse bone marrow-
derived DCs were generated by exposure of cells to LPS, 
thereby inducing immune-stimulatory DC (LPS-DC), or 
to 1α,25-dihydroxyvitaminD3, thereby inducing immune-
suppressive DC (VitD3-DC) [56]. Untreated DC were used 
as control cells. The different DC subtypes displayed the 
expected differences in expression of the activation mark-
ers, with LPS-DC showing increased levels of MHC class 
II and CD86 expression, while VitD3-DC showed increased 
PD-L1/CD86 ratios [57] and resistance to LPS activation 
[58] (Supplementary Fig. 1A–F). We isolated EV from 
cell culture supernatant of LPS-DC, VitD3-DC, and con-
trol DC using differential (ultra)centrifugation followed 
by density gradient separation, as previously published by 
our group (Supplementary Fig. 2A and [52]). Transmission 
electron microscopic analysis indicated that low-density 
fractions contained 100–150 nm-sized EV, whereas no EV 
were observed in high-density fractions enriched in protein 
complexes (Supplementary Fig. 2B). Our in-house devel-
oped high-resolution flow cytometric method was used for 
*
*
n.s.
*
RNA yieldEV counta b
Fig. 1  LPS- and VitD3-stimulated DCs release different numbers 
of extracellular vesicles. a EV derived from equal numbers of con-
trol, and LPS- and VitD3-treated DC were fluorescently labeled 
using PKH67, separated from RNPs and free dye by sucrose density 
centrifugation, and quantified by high-resolution flow cytometry. 
Indicated are the number of fluorescent events detected in 30 s, nor-
malized to the control condition (mean ± SD of n = 3 independent 
experiments, one-way ANOVA with Dunnett’s two-sided post hoc 
test, *p < 0.05. b Bioanalyzer-based quantification of RNA isolated 
from EV derived from equal numbers of cells purified by density gra-
dient centrifugation. Small RNA yields were normalized to the con-
trol DC condition. Indicated are the mean ± SD values of n = 4 inde-
pendent experiments (one-way ANOVA with Dunnett’s two-sided 
post hoc test, *p < 0.05)
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high-throughput EV analysis at the single particle level [49, 
52]. The light scatter patterns induced by EV from differ-
ently stimulated DC were highly similar (Supplementary 
Fig. 2C). However, we detected differences in the number 
of released EV, with LPS-DC releasing more, and VitD3-
DC releasing less EV than non-treated control DC (Fig. 1a). 
These quantitative differences were confirmed by nanopar-
ticle tracking analysis (NTA) (Supplementary Fig. 2D). In 
addition, the NTA data indicated that the majority of EV 
observed in all conditions were in the 100–200 nm size 
range. Western blot analysis showed that the DC-derived 
EV contained variable levels of common EV proteins such 
as CD9, MHCII, CD63, and Galectin-3 [59], whereas abun-
dant cellular proteins such as beta-actin were not detected 
(Supplementary Fig. 2E). These data demonstrate that VitD3 
and LPS treatment of DC differentially affect the number 
and protein content of EV released by these cells.
Next, we analyzed how LPS- or VitD3 treatment of DC 
affected the RNA content of EV released by these cells. It 
is important to note that extracellular RNA can be associ-
ated with either EV or ribonucleoprotein complexes, which 
may sediment at similar centrifugal force [4]. Using density 
gradient-based purification, we separated EV from con-
taminating ribonucleoprotein complexes. Depending on 
the differentiation status of the parental DC, the EV-free 
ribonucleoprotein fraction contained between 26 and 55% 
of total extracellular RNA released from cells (Supplemen-
tary Fig. 2F–G). The total amount of EV-associated RNA 
released by equal numbers of control, LPS-, and VitD3-
treated DC was different and reflected the differences in 
EV numbers (Fig. 1a, b). To assess whether DC stimulation 
altered the RNA composition of EV, we prepared sequenc-
ing libraries of EV-associated and cellular small RNA from 
control-, LPS-, and VitD3-DC cultures (n = 3 biological 
replicates). Sequencing libraries were prepared using an 
adapter-ligation-based method routinely used in miRNA 
profiling [60]. Such a method has been frequently applied 
in studies to demonstrate the presence of miRNA and other 
small non-coding RNA types in EV (e.g., [23, 24, 31, 32, 
61]). All libraries contained RNAs with lengths ranging 
between 20 and 300 nucleotides. Since short RNA mole-
cules have a selective advantage during PCR amplification 
and pre-amplification on the sequencing flow-cell, leading 
to an apparent over-representation of short read lengths, 
we enriched the libraries for longer RNAs to ensure suf-
ficient coverage of these sequences. To this end, cellular 
and EV-associated cDNA libraries were split into different 
size fractions of 15–25 nt (includes miRNAs), 25–60 nt, 
60–80 nt (includes tRNAs), and 80–275 nt. Subsequently, 
we enriched for longer RNA molecules by pooling these 
size fractions in a volumetric ratio of 2:2:3:3 (for details, see 
“Materials and methods”). This, indeed, resulted in a better 
coverage of 100–300 nt mid-size RNAs, such as full-length 
Vault RNA (142 nt) (Supplementary Fig. 3). More than 13 
million reads were obtained for each library (Supplemen-
tary Table 1). Pearson coefficients for biological replicate 
samples were ≥ 0.85 for EV, and ≥ 0.95 for cells (Supple-
mentary Fig. 4). As expected based on the previous studies 
[23, 30–32, 34], we detected the presence of various small 
RNA classes in EV (miRNA, snoRNA, snRNA, tRNA, mis-
cRNA, and rRNA). Some RNA types were enriched in EV, 
such as Y-RNA, Vault RNA, and 7SL RNA classified as 
‘miscRNA’, while other RNA types, such as snoRNA, were 
relatively less abundant in EV compared to cells (Fig. 2). 
Since we depleted ribosomal RNA before preparation of 
the sequencing libraries, apparent enrichment of rRNA in 
EV is probably caused by differences in depletion efficiency 
between cells and EV. MiRNA and snRNA abundance was 
similar between cells and EV. Stimulation of DC with LPS 
or VitD3 did not lead to major changes in the distribution of 
sequencing reads over different RNA classes in EV and cells 
(Supplementary Fig. 5A–B).
Next, we assessed whether, within each of the different 
classes, the levels of individual RNAs in EV changed as a 
result of cell stimulation. Hereto, read counts were normal-
ized per RNA class, after which the fold changes in reads 
*
* *
a b c
d e f
Fig. 2  Cells and EV differ in the relative abundance of different small 
RNA classes. a–f The relative abundance of the indicated ncRNA 
classes in cells versus EV was assessed by small RNAseq analysis 
of cellular and EV-associated RNA. Total read count for each RNA 
class was normalized to total library size. To compare the distribution 
of ncRNA classes between cells and EV, normalized RNA class read 
counts in EV were scaled to the normalized RNA class read counts 
in cellular RNA (set to 1). Indicated are mean values ± SD of n = 3 
independent experiments (two-tailed t test on normalized CPM val-
ues, *p < 0.05)
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per million (RPM) of individual RNAs in LPS or VitD3 
over control conditions were calculated. The scatter plots in 
Fig. 3a–e display the log-fold changes induced by LPS ver-
sus VitD3 treatment for the indicated RNA classes (dashed 
lines correspond to a log2fold change of 1). Dot size indi-
cates the average (n = 3) abundance of a transcript in EV 
and RNAs with non-adjusted p < 0.05 are highlighted in 
black. The scatter plots of these data indicated that LPS- 
and VitD3-treatment affected the levels of miRNA, snoRNA, 
snRNA, and miscRNA in EV (Fig. 3a–e). Some of the stim-
ulation-induced changes were similar for LPS and VitD3 
conditions, while other RNAs show opposing alterations, or 
change only in one of the stimulation conditions.
Of the tested RNA classes, tRNA levels in EV showed 
the lowest rate of change due to LPS or VitD3 stimulation. 
97% of tRNA reads mapped to six different tRNA isoaccep-
tors (GluCTC, GlyGCC, LysCTT, GluTTC, GluCTG, and 
LysTTT) (Supplementary Fig. 6A). Although relatively high 
tRNA read counts were observed in the EV-associated RNA 
pool (Supplementary Fig. 5B), the levels of these six abun-
dant tRNAs remained stable (log2FC < 1) in response to cel-
lular stimulation (Supplementary Fig. 6B). Besides tRNAs, 
the highly purified EV populations used in this study also 
contained substantial levels of snRNA, which is an RNA 
type known to be mainly confined to the nucleus. Although 
cell stimulation seemed to induce changes in EV-associated 
snRNA levels (Fig. 3c), many of the individual data points 
mapped to multicopy genes with highly similar sequences 
(> 95% sequence identity) corresponding to known snRNAs. 
Cumulative analysis of these multicopy genes indicated that 
96% of snRNA reads mapped to four different snRNAs (U1, 
U2, U5, and U6) (Fig. 4a), of which the levels in EV did 
not significantly differ between stimulation versus control 
conditions (Fig. 4b). Thus, the levels of snRNAs and tRNAs, 
Fig. 3  LPS- versus VitD3-induced changes in EV-associated RNA 
classes. EV-associated RNA from control, LPS, and VitD3 condi-
tions was isolated and analyzed by RNA sequencing. Read counts 
for individual RNAs were normalized to the total read counts of 
each RNA class. a–e LPS- or VitD3-induced fold changes and cor-
responding p values were calculated relative to the control condition 
with edgeR GLM method. Data are expressed as log2fold change in 
LPS-EV relative to control-EV versus log2fold change in VitD3-EV 
relative to control-EV. Cutoffs for log2fold changes larger or smaller 
than 1 are indicated with dashed lines (red = LPS; green = VitD3), so 
all data points beyond these lines are differentially expressed with 
log2FC > 1. Dot size represents the normalized abundance (logCPM) 
of individual RNAs. RNAs that changed with non-adjusted p < 0.05 
are highlighted in black
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which are commonly detected RNA types in EV, remained 
constant upon different immune stimuli imposed on the EV-
producing cells.
In contrast to tRNAs and snRNAs, the EV-associated 
levels of three other RNA types tested here, i.e., miRNAs, 
snoRNAs, and miscRNAs, changed in response to the differ-
ent stimulate imposed on the DC. We aimed to identify the 
RNAs differentially present in EV released by LPS- versus 
VitD3-treated DC, since such RNAs may underlie distinct 
effects of EV on recipient cells.
Within the miRNA group, we observed the highest num-
ber of RNAs that differed between the LPS and VitD3 groups 
with a fold change > 2 and with FDR values < 0.05 (Fig. 5a, 
red dots). Interestingly, for the majority (15 out of 20) of the 
top miRNAs that differed significantly between VitD3 and 
LPS conditions with lowest FDR values, DC functions have 
been described previously (Table 1 and [62–73]).
MiRNAs known to be involved in the pro-inflammatory 
function of DC were enriched in LPS-induced EV, whereas 
EV from VitD3-treated DC were enriched in miRNAs that 
dampen immune-stimulatory signaling cascades in DC. We 
validated three LPS-enriched and three VitD3-enriched 
RNAs by RT-qPCR. The use of stable reference transcripts 
in RT-qPCR analysis is important to ensure reliable normali-
zation between different samples. However, the identity and 
general applicability of reference transcripts stably present 
in EV are understudied. Here, we used our sequencing data 
set to select four non-coding RNAs that were present in EV 
at comparable levels across all conditions, and confirmed 
their stability by RT-qPCR (Supplementary Fig. 7A–B). 
We normalized our qPCR data to the geometric mean of 
these four genes to minimize errors caused by technical 
and/or biological variation [74]. Using this normalization 
strategy, RT-qPCR analysis confirmed the sequencing data 
for the tested miRNAs, although miR146-5p did not reach 
significance (Fig. 5b). Together, these data indicate that 
opposing stimuli imposed on the same type of parental cell 
induce the release of functionally different sets of miRNAs 
via EV.
Besides changes in miRNA levels, the levels of several 
EV-associated snoRNAs were found to differ between LPS 
and VitD3 conditions (Fig. 5c), with three H/ACA box 
snoRNAs (snora2b, snora32, and snora55) displaying FDR 
levels < 0.05. The overall low abundance of this RNA class 
in EV (Fig. 2c) hampered reliable quantification of snoR-
NAs in EV by RT-qPCR (data not shown). Nevertheless, 
our data are a first indication that EV-associated snoRNA 
levels change with the activation status of parental cells. 
Although none of the RNAs in the miscRNA group reached 
FDR levels < 0.05, analysis by RT-qPCR indicated that 
the levels of Y3-RNA (Rny3) and an additional member 
of the Y-RNA family, Y1-RNA (Rny1), significantly dif-
fered between LPS and VitD3 conditions (Fig. 5d, e). In 
cells, the conserved family of Y-RNAs is known to bind to 
several different proteins that play a role in RNA quality 
control [75, 76]. Members of the small non-coding Y-RNA 
family have frequently been detected in EV from multiple 
different cell types and different body fluids [30–32, 34, 35, 
77–81]. We here provide evidence that Y-RNA levels in EV 
can be regulated by stimuli imposed on the EV-producing 
cell. The reduced Y-RNA levels in EV from LPS-stimulated 
DC compared to EV from VitD3-stimulated DC (Fig. 5e) 
indicate that the presence of Y-RNAs in EV may be indica-
tive for the immune function of the parental cells. Overall, 
our data indicate that immune cell stimuli cause changes 
in the EV-associated levels of specific miRNAs, snoRNAs 
and Y-RNAs.
So far, we compared the abundance of specific RNA 
classes in EV by assessing the total numbers of reads 
mapping to non-coding RNA genes. However, also the 
Fig. 4  EV from LPS- and VitD3-stimulated DC display stable lev-
els of abundant snRNAs. EV-associated RNA from control, LPS, 
and VitD3 conditions was isolated and analyzed by RNA sequenc-
ing. Read counts for individual RNAs were normalized to the total 
read counts of each RNA class. a Read counts for the top-four most 
abundant snRNAs, constituting 96% of snRNA reads in EV-RNA, are 
expressed as percentage of the total snRNA read count in EV. b Data 
from a are expressed as fold change in the indicated snRNA levels of 
VitD3- or LPS-EV relative to control-EV (mean ± SD of n = 3 experi-
ments; in one-way ANOVA, no significant differences were observed)
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fragmentation profile of EV-associated RNAs may be 
functionally important and indicative for the status of the 
EV-producing cell. Fragmented forms of RNA have been 
described in EV from a wide range of cells and biological 
fluids [30–32, 34, 35, 77, 78, 81]. Especially, Y-RNA 
fragments (19–35 nt) have gained attention, because they 
were found to associate with Argonaute, suggesting scope 
for gene-regulatory functions [82, 83], and because their 
LPS-enrichedVitD3-enriched
miRNA
snoRNA
miscRNA
LPS-enrichedVitD3-enriched
LPS-enrichedVitD3-enriched
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presence in plasma has been linked to disease [78, 84]. We 
examined our data to determine whether reads mapping 
to Y-RNAs included these fragments in the purified DC-
derived EV. Based on RNAseq data, 5′ and 3′ fragments of 
Y1-RNA were present in EV and such fragments seemed 
more abundant than the full-length form of this Y-RNA 
(Fig. 6a). To confirm the full-length or fragmented nature of 
the Y-RNA molecules, we performed Northern blot analysis. 
Using probes recognizing the 5′ and 3′ end of Y1-RNA, we 
found that both 5′ -and 3′ fragments and full-length Y-RNA 
could be detected in both cellular and EV-RNA (Fig. 6b–d). 
Strikingly, the relative amount of full-length Y1-RNA 
detected by Northern blot was much higher than expected 
based on the sequencing coverage plots. This indicates that 
RNAseq-based detection of the full-length form of Y1-RNA 
was highly inefficient. This is likely due to the 5′-triphos-
phate group of full-length Y-RNAs or their strong secondary 
structure, which may hamper sequencing adaptor ligation 
and thereby efficient amplification and sequencing of these 
RNAs. Interestingly, Northern blot analysis also indicated 
that the levels of full-length Y1-RNA in LPS-EV were 
reduced, which was in accordance to the RT-qPCR analysis 
for full-length Y1 (Fig. 5e), while the levels of fragmented 
Y1-RNA in EV remained relatively stable (Fig. 6d). These 
data urge caution in classifying fragmented and full-length 
forms of Y-RNA based on RNA sequencing data.
Changes in the RNA content of EV have been suggested 
to directly reflect changes in the RNA levels of the paren-
tal cell. To test this hypothesis, we investigated whether 
all of the stimulation-induced changes in miRNAs, snoR-
NAs, and miscRNAs observed in EV reflected changes 
in the RNA pool of the parental cells and vice versa. 
After normalization within each RNA class, fold-changes 
in EV were plotted against the fold changes in cells for 
miRNA, miscRNA, and snoRNA (Fig. 7a), with dashed 
lines indicating log2FC of 1 or − 1. Dot size indicates the 
average (n = 3) abundance of a transcript in EV, and dot 
coloring is used to indicate RNAs that were significantly 
changed in cells, EV, or both. First, we tested whether 
changes in EV-associated RNAs reflected stimulation-
induced changes in cells. RNAs of which the levels in EV 
significantly changed (non-adjusted p values < 0.05) upon 
LPS or VitD3-treatment were categorized as ‘reflective 
RNAs’ (p < 0.05 in both cells and EV), ‘EV-responsive 
RNAs’ (p < 0.05 in EV, p > 0.05 in cells), or ‘reciprocal 
RNAs’ (opposite changes in EV and cells with p < 0.05) 
(Supplementary Table 2). Of all RNAs that significantly 
changed in EV (set to 100%), a minor percentage of the 
miRNAs and snoRNAs reflected the up/downregulation 
in cells or were reciprocally regulated, while most of 
the RNAs changed only in EV, but not (significantly) in 
cells (Fig. 7b–d). Conversely, we aimed to assess which 
proportion of LPS- or VitD3-induced changes in cellu-
lar RNA was reflected in the EV-RNA content. RNAs 
that changed in cells upon cell stimulation (non-adjusted 
p values < 0.05) were, therefore, classified as ‘reflec-
tive’ (p < 0.05 in both cells and EV), ‘cell-responsive’ 
(p < 0.05 in cells, p > 0.05 in EV), ‘reciprocal’ (opposite 
changes in EV and cells with p < 0.05), or ‘not in EV’ 
(p < 0.05 in cells, but not detected in EV). Comparable 
to what we observed in the above analysis of EV-RNA, 
only a minor percentage of changes in cellular miRNAs 
and snoRNAs was reflected in EV. The majority of the 
RNAs that changed in cells did not significantly change 
in EV (Fig. 7e–g), and 10–20% of the RNAs that changed 
in cells were not detected in EV. We selected three reflec-
tive and three EV-responsive RNAs (Fig. 7h) for valida-
tion by RT-qPCR. For the reflective miRNAs miR-155, 
-9, and -10a, we confirmed that the stimulation-induced 
fold-change in EV-associated and cellular RNA was highly 
similar. For the EV-responsive miRNA miR-146a and the 
two Y-RNAs, significant cell stimulation-induced changes 
were observed in EV, while cellular levels did not change 
significantly compared to the control conditions. Impor-
tantly, these data indicate that part of the cell stimulation-
induced changes in EV-RNA content match the changes 
observed in cellular RNA, but that cell stimulation also 
induces changes in RNA levels that are only observed in 
cells or in EV.
Overall, the results obtained for our primary DC cul-
tures show that the molecular messages enclosed in EV 
are composed of multiple RNA classes that are specifically 
shuttled into EV dependent on the activation status of the 
Fig. 5  EV from LPS-/VitD3-stimulated DC display differences in 
the levels of several miRNAs, snoRNAs, and Y-RNAs. EV-asso-
ciated RNA from control, LPS, and VitD3 conditions was isolated 
and analyzed by RNA sequencing. Read counts for individual RNAs 
were normalized to the total read counts of each RNA class. LPS- or 
VitD3-induced fold changes and corresponding p values were calcu-
lated relative to the control condition. a Volcano plots of EV-associ-
ated miRNAs in LPS versus VitD3 conditions. Thresholds for twofold 
change and non-adjusted p < 0.05 are indicated. Data points represent 
average values of n = 3 biological replicates. Significant changes are 
indicated with different colours. Grey: non-significant, blue: non-
adjusted p value < 0.05, and red: FDR < 0.05. b RT-qPCR validation 
of six miRNAs showing differential abundance between LPS-EV 
and VitD3-EV. Data are expressed as log2fold change in LPS- and 
VitD3-EV compared to control-EV. Indicated are the mean ± SD val-
ues of n = 4 independent experiments, one-way ANOVA, *p < 0.05. 
Volcano plots of EV-associated snoRNAs (c) and miscRNAs (d) in 
LPS versus VitD3 conditions. Thresholds for twofold  change and 
non-adjusted p < 0.05 are indicated. Data points represent average 
values of n = 3 biological replicates. Significant changes are indi-
cated in different colours. Grey: non-significant, blue: non-adjusted 
p value < 0.05, red: FDR < 0.05. e RT-qPCR validation of Y3 and its 
family member Y1 showing differential abundance between LPS-EV 
and VitD3-EV compared to control-EV. Indicated are the mean ± SD 
values of n = 4 independent experiments, one-way ANOVA, *p < 0.05
◂
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Table 1  MicroRNAs enriched in LPS- or VitD3-EV with known functions in DC
EV-associated RNA from control, LPS, and VitD3 conditions was isolated and analyzed by RNA sequencing. Read counts for individual RNAs 
were normalized to the total read counts of each RNA class. LPS- or VitD3-induced fold-changes and corresponding p values were calculated 
relative to the control condition with edgeR GLM method. We created a top 20 list of miRNAs with the lowest FDR values. Indicated are miR-
NAs from this top 20 for which DC-related functions have been reported
Identifier Enriched in FDR Function in DC References
mmu-miR-155-5p LPS-EV 4.04E−12 Master regulator in DC maturation [62]
mmu-miR-708-3p VitD3-EV 2.21E−09 Downregulated in mature/activated DC [63]
mmu-miR-10a-5p VitD3-EV 2.31E−07 Inhibits DC activation and Th1/Th17 cell immune responses [64]
mmu-miR-146a-5p LPS-EV 4.53E−06 Down regulates IL-12p70, IL-6, and TNF-α production by DC [65]
mmu-miR-9-5p LPS-EV 1.86E−05 Regulatory circuitry controlling monocyte activation by LPS [66]
mmu-miR-223-5p VitD3-EV 6.82E−05 Repression of pro-inflammatory cytokine release by DC [67]
mmu-miR-378a-3p VitD3-EV 8.24E−05 Upregulated in VitD3-treated DC [68]
mmu-miR-203-3p VitD3-EV 0.000328 Upregulated in tolerogenic DC [69]
mmu-miR-199a-3p VitD3-EV 0.000484 Upregulated in tolerogenic DC [69]
mmu-miR-27b-5p VitD3-EV 0.000578 Suppression of inflammatory cytokine production via NF-κB [69]
mmu-miR-7a-5p LPS-EV 0.000703 Upregulated in LPS/IFNg stimulated DC [69]
mmu-miR-126a-3p VitD3-EV 0.000946 Reduces the responsiveness of DCs to TLR7/9 ligands [70]
mmu-miR-708-5p VitD3-EV 0.000946 Suppresses NF-κB signaling [71]
mmu-miR-181b-3p VitD3-EV 0.001923 Inhibition of CD40 and MHCII expression [72]
mmu-miR-27a-5p VitD3-EV 0.002511 Suppression of inflammatory cytokine production [73]
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Fig. 6  Full-length versus fragmented forms of Y1-RNA in cells and 
EV validated by Northern blot. a Representative coverage plot of 
Y1-RNA as observed in EV-RNA seq data (sequencing coverage 
depth 3981) visualized in the UCSC genome browser. b RNA iso-
lated from control, LPS, and VitD3-treated cells and their EV were 
analyzed by Northern blot for the detection of full-length (FL) and 
5′fragments (5p) of Y1-RNA using Y1-5p probe. 10 ng of small RNA 
was loaded per lane. c Northern blot detection of full-length (FL) and 
3′fragments (3p) of Y1-RNA using Y1-3p probe. 10 ng of small RNA 
was loaded per lane. d Northern blot detection of full-length and 
5′fragments of Y1-RNA in EV-RNA from differently stimulated DC 
(C = control, L = LPS, V = VitD3). 10  ng of small RNA was loaded 
per lane. Data are representative for n = 2 independent experiments
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cell. Moreover, the stimulus-induced changes in the small 
RNA content of cells and EV only partly overlap.
Discussion
The data presented here broaden our view on the plasticity 
of the small RNA content of EV in relation to changes in 
the activation status of the EV-producing cell. Whereas 
most of the previous studies focused on the miRNA con-
tent of EV, we show that cell status-dependent changes in 
the RNA composition of EV also extend to other small 
RNA classes, which may, therefore, also contribute to the 
specific genetic messages conveyed by EV to recipient 
cells. The immune cell model which we employed, i.e., DC 
that are well known for their strong and diverse functional 
responsiveness to external stimuli, served two purposes. 
First, the cell system illustrates that diverse stimuli can 
induce the release of EV with variable levels of multiple 
RNA types, and that only some of the stimulation-induced 
changes in EV-associated RNAs reflect changes in the 
cellular RNA. Second, the data extend our knowledge on 
the central role of DC in raising and regulating immune 
responses. The identification of multiple EV-RNA types 
that are specifically associated with either the immune-
activating or immune-suppressing status of DC is the prel-
ude to unraveling the function of these RNAs in EV.
So far, RNA sequencing studies in which multiple 
RNA classes were identified in EV employed EV isolation 
methods known to co-isolate extracellular protein–RNA 
complexes (RNP) that overlap in size with EV, e.g., ultra-
centrifugation and precipitation-based methods [4, 24, 
30, 32, 34, 80, 85, 86]. The results of our present study 
indicate that up to 55% of total extracellular RNA pre-
sent in ultracentrifugation pellets of cell culture superna-
tant can be associated with RNPs. Buoyant density-based 
separation of EV from RNP, as employed in this study, 
allowed us to specifically identify RNA species that cells 
differentially sort into EV upon exogenous stimulation. 
In RNA sequencing libraries prepared from these highly 
pure EV, we observed that the percentage of alignment to 
the mouse genome was lower than in cellular RNA librar-
ies. This is likely caused by the (ultra)low-input quantity 
of RNA in our EV-sequencing libraries, which amplifies 
the contribution of lab-derived contaminant RNAs, e.g., 
from commercial nucleic acid extraction kits or sample 
cross-contamination [87, 88]. The percentage of align-
ment may also be dependent on the size range of RNAs 
selected for sequencing. Whereas, in most published EV-
RNA sequencing studies, RNAs in the 20–40 nt size range 
were sequenced, thereby strongly selecting for microR-
NAs, we here sequenced RNAs of a much larger size range 
(20–300 nt). We previously showed that several of these 
larger and highly modified/structured RNAs, for which the 
sequencing efficiency may be compromised, are enriched 
in EV compared to cellular RNA [30], which may have 
caused the percentages of alignment to be lower in EV 
compared to cells. For our studies, we selected a com-
mercial adapter-ligation-based method that has been fre-
quently used in EV-RNA sequencing studies [23, 24, 31, 
32, 61]. While optimized for miRNA analysis, it should be 
noted that these library preparation methods show bias in 
the efficiency with which sequences with base modifica-
tions, terminal triphosphate groups, and strong secondary 
structures are ligated and sequenced [89]. As an example, 
we here provide Northern blot-based evidence that the 
frequently reported predominance of Y-RNA fragments 
over full-length Y-RNA in EV [30, 32, 35, 90] represents 
a sequencing artefact. We observed a similar discrepancy 
between sequencing read coverage and Northern blot anal-
ysis for tRNAs (Supplementary Fig. 8). While the triphos-
phate group on the 5′-end [91] or their strong secondary 
structure may hamper efficient sequencing of full-length 
Y-RNA, difficulties with sequencing of full-length tRNAs 
are likely due to the inability of the reverse transcriptase 
enzyme used during sequencing library preparation to 
read through the highly modified tRNA structure [92]. 
This is corroborated by recent sequencing studies deploy-
ing reverse transcriptases that are insensitive to second-
ary RNA structures [93, 94]. Together, these findings urge 
caution in the interpretation of RNA fragmentation based 
on RNA sequencing data alone. Moreover, we reduced the 
effect of sequencing biases on the assessment of quantita-
tive differences in EV-RNA content by determining the 
fold changes in identical transcripts between different 
conditions.
Our experimental approach allowed comprehensive 
analysis of changes in EV-RNA classes induced by diverse 
immune-relevant stimuli. The most prominent stimulation-
induced changes in EV-associated RNA levels were found 
for miRNA, Y-RNA, and snoRNAs (Fig.  3). Although 
detected in EV from multiple sources [23, 31, 33–35], the 
presence of snoRNAs in EV has been largely understud-
ied. Here, we provide evidence that the levels of EV-associ-
ated snoRNAs can be regulated by stimuli imposed on the 
EV-producing cell. Since changes in the cellular levels of 
snoRNA have been associated with diseases [36, 95, 96], our 
present data point to EV-associated snoRNAs as potential 
functional entities in EV and interesting candidate biomark-
ers indicative of the cellular activation status.
Numerous studies already demonstrated that miRNA 
levels in EV change upon disease induction or cell stim-
ulation [22–24]. Unique aspects of our present RNAseq 
study are the use of two different stimuli for comparative 
analysis of RNA levels in highly purified EV and the par-
allel assessment of cellular and EV-associated RNA. The 
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enrichment of endotoxin-responsive miRNAs, such as miR-
155 and miR-146a [20, 97, 98], that we observed in EV 
from LPS-stimulated DC concurs with previously published 
semi-quantitative microarray-based data on the miRNA 
content of EV from stimulated DC [22, 26]. Both miR-155 
and miR-146a are known to be endotoxin-responsive, but 
miR-155 has an immune-activating role, while miR-146a is 
involved in dampening of immune responses and could act 
as a molecular brake on inflammation [99]. It is thought that 
the coordinated action of these two is important in regula-
tion of immune response [21]. Differences in the miR-155/
miR-146a ratios that we observed in LPS-EV and VitD3 EV 
(Fig. 5b) may, therefore, lead to different effects of these EV 
on immune activation. In addition, we here demonstrated 
that a different (i.e., immune downregulatory) type of stimu-
lus imposed on DC led to both a reduction of EV-associated 
levels of these immune-activating miRNAs and an enrich-
ment in miRNAs implicated in the suppression of immune 
responses via modulation of multiple pathways. Examples 
include dampening of TLR signaling by miR-27a and miR-
126a [70, 73], and downregulation of (regulators of) PI3K/
Akt and NF-κB by miR-378 [100], miR-708 [71] and miR-
27b-3p [101], processes that have been implicated in the 
suppression of pro-inflammatory cytokine release. Such dif-
ferences in the EV-miRNA content may therefore contribute 
to immune-activating or immune-suppressive functions of 
differentially stimulated DC.
Not only immune-suppressive miRNAs but also two types 
of Y-RNA were found to be specifically excluded from EV 
released by LPS-stimulated DC (Fig. 5e). This raises the 
question whether Y-RNAs contribute to immune-related 
functions of EV. Until now, different types of Y-RNA (mY1 
and mY3 in mice and hY1, hY3, hY4, and hY5 in humans) 
have been detected in EV from a multitude of different cell 
types and in different body fluids [30–32, 34, 35, 77–81]. 
The extracellular presence of Y4- and Y5-RNA and frag-
ments thereof has mostly been associated to cancer [32, 81, 
84, 102] and coronary artery disease [78, 103]. Immune-
related functions of Y-RNAs include their capacity to trig-
ger TLR signaling. Interestingly, Y-RNAs may vary in their 
specificity for different TLRs, with Y3-RNA triggering 
predominantly TLR3, while Y1-, Y3-, and Y4-RNA trig-
ger TLR7 [104]. On the contrary, the reduction of Y1- and 
Y3-RNA levels in EV released by immune-stimulatory DC, 
shown in this study, suggests an immune downregulatory 
role for these EV-associated Y-RNAs. In line with this, high 
levels of Y-RNAs have been reported in immune-suppressive 
EV released by the parasite Heligmosomoides polygyrus and 
in seminal fluid EV for which immunosuppressive effects 
have been described [35, 105–107]. Overall, the observed 
variable presence of Y-RNA in EV from immune cells has 
raised further interest in unraveling the immune-related 
function and biomarker potential of these RNAs in EV.
With regard to the biomarker potential of EV-associ-
ated RNAs, our data also urge caution in interpreting EV 
as snapshots of the cell from which they arise. We found 
that only a subset of changes in EV-RNA reflected changes 
that occurred at the cellular level. The highest proportion of 
reflective RNAs was observed within the category of miR-
NAs and included prominent immune-related RNAs such as 
miR-155, miR-9, and miR-10-5p (Fig. 7h). For a substantial 
number of EV-associated miRNAs and both Y-RNA types, 
however, stimulation-induced changes were observed in EV, 
but not in cells. This could suggest that EV-levels of reflec-
tive RNAs are mainly regulated by transcription, whereas 
levels of EV-responsive RNAs are mainly determined by 
shuttling rate. For RNAs known to primarily reside in the 
nucleus (such as snRNAs and snoRNAs), subtle changes 
in the cytoplasmic pool of these RNAs may be overshad-
owed by the much larger nuclear pool. Comparison of EV-
associated levels with cytoplasmic instead of total cellular 
RNA levels may, therefore, provide a better insight in shut-
tling of these nuclear RNAs into EV. Interestingly, we also 
observed that many of the stimulation-induced changes in 
cellular RNA levels were not reflected in the RNA levels of 
EV released by these cells. This strengthens the hypothesis 
that cells release EV with selective sets of RNAs into the 
extracellular milieu. From a biomarker perspective, these 
Fig. 7  LPS-/VitD3-induced changes in cellular versus EV-associated 
RNA levels. Cellular and EV-associated RNA from control, LPS, 
and VitD3 conditions was isolated and analyzed by RNA sequenc-
ing. Read counts for individual RNAs were normalized to the total 
read counts of each RNA class. LPS- or VitD3-induced fold changes 
and corresponding p values were calculated relative to the control 
condition for cellular and EV-associated RNA. a Fold changes in 
EV-RNAs were plotted against the fold changes in cellular RNA in 
response to LPS (top graphs) and VitD3 (lower graphs) for miRNA 
(left), miscRNA (middle), and snoRNA (right). Dashed lines indicate 
log2FC larger or smaller than 1, so all data points beyond these lines 
are differentially expressed with log2FC > 1. Colored dots indicate 
transcripts that changed with non-adjusted p values < 0.05 in cells 
(blue), in EV (red), or in both cells and EV (purple), grey dots indi-
cate unchanged transcripts. Dot size represents the normalized abun-
dance (logCPM) of individual RNAs, mean of n = 3 experiments. b–d 
Transcripts showing significant changes in stimulated versus control 
EV (p value < 0.05) were selected, and fold changes in EV versus cor-
responding cells were compared. Indicated are percentages of tran-
scripts categorized as ‘reflective’ (p value < 0.05 in EV and cells), 
‘EV-responsive’ (p value < 0.05 in EV but not in cells), and ‘recipro-
cal’ (p value < 0.05 in cells and EV, but with opposite fold changes). 
e–g Analogous to b–d, transcripts showing significant changes in 
cells (p value < 0.05) were selected, and fold changes in cells were 
compared with those in EV. Indicated are percentages of transcripts 
categorized as ‘reflective’, ‘reciprocal’, cell-responsive (p value < 0.05 
in cells but not in EV), or ‘not in EV’ (transcripts only found in cells). 
h RT-qPCR validation of six genes that were found to be reflective 
(left panels) or EV-responsive (right panels) on EV-associated RNA 
and cellular RNA from control, LPS- or VitD3-treated DC. Fold 
changes in EV and in cells were calculated relative to the control con-
dition in cells or EV. N = 4, one-way ANOVA, *p < 0.05
◂
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data implicate that, although the presence of specific EV-
RNAs may correlate with disease, the EV transcriptome is 
not necessarily predictive for RNA levels in the EV-pro-
ducing cell.
We observed two classes of RNA, i.e., snRNA and 
tRNA, of which the EV-associated levels remained stable 
after differential stimulation of DC. These RNA classes 
have been commonly detected in small RNAseq studies of 
EV from multiple cell types and body fluids, but factors 
impacting their incorporation into EV had until now not 
been investigated. Although these data need confirmation 
in different cell types with various external stimuli, our 
data may be a first indication that tRNAs and snRNAs 
are constitutive components of EV. Speculatively, these 
RNAs may be required for basal scaffolding functions 
in EV biogenesis, or may aid the functional transfer of 
gene-regulatory RNAs. Based on their stable association 
with EV, these types of RNAs also have potential to be 
used as EV-reference RNAs for RT-qPCR normalization, 
since comparing the EV transcriptome of differentially 
stimulated cells is complicated by potential differences 
in the number of EV, RNA yield, and RNA composition. 
Importantly, the use of well-known stably expressed cel-
lular RNAs is not necessarily valid for normalization of 
EV qPCR data due to potential differences in RNA shut-
tling between tested conditions. Therefore, normalization 
of RT-qPCR data to reference genes which are stable in 
EV is a reliable way to quantitate differences in individual 
RNAs. Here, we show how RNA sequencing and RT-qPCR 
validation can be used to identify candidate EV-reference 
genes which are constitutively expressed between differ-
ently stimulated cells.
In conclusion, this study indicates that external stim-
uli imposed on cells can lead to changes in the levels of 
some EV-associated RNA classes, while leaving others 
unchanged. In our DC-model, two different immune-
related cell stimuli led to disparate changes in the type 
and quantity of miRNAs, snoRNAs, and Y-RNAs in EV. 
Only part of the changes in RNA contents of EV reflected 
changes in the cellular RNA, which urges caution in inter-
preting EV as snapshots of cells. These findings show that 
differences in multiple structurally distinct RNA classes 
shape the EV transcriptome. These RNA types may con-
tribute to the functional properties of EV in cellular com-
munication, and may be further explored as candidate 
EV-RNA-based indicators for the immune status of the 
EV-producing cell.
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